Related Experiment Videos
Disruption of the Keap1-containing ubiquitination complex as an antioxidant therapy
Jonathan T Kern1, Mark Hannink, J Fred Hess
1Neuroscience Drug Discovery, Merck Research Laboratories, Merck and Co., Inc., 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA. jonathan_kern@merck.com
Abstract:
The transcription of antioxidant response element (ARE)-containing cytoprotective genes has been proposed as a means to combat oxidative stress-related disorders, such as cancer and Parkinson's disease. Transactivation of the ARE requires the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). Cellular levels of Nrf2 protein are regulated by the Kelch-like ECH-associated protein 1 (Keap1), a substrate adaptor protein for the ubiquitin ligase machinery and subsequent proteasomal degradation. Recently, detailed studies have elucidated the structure and interactions of the Keap1-containing ubiquitin ligase complex. Here, we propose that small molecule modulation of Keap1 protein:protein interactions may permit Nrf2's nuclear accumulation and the transcription of ARE-dependent genes to enhance cellular resistance to oxidative insult.
Insights
Targeting Keap1 protein interactions could activate Nrf2, promoting antioxidant gene transcription. This approach may enhance cellular defense against oxidative stress disorders like cancer and Parkinson's disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Biology
Background:
- Oxidative stress contributes to diseases like cancer and Parkinson's.
- Antioxidant Response Element (ARE) genes protect cells from oxidative damage.
- Nuclear factor erythroid 2-related factor 2 (Nrf2) activates ARE genes.
- Kelch-like ECH-associated protein 1 (Keap1) regulates Nrf2 stability via ubiquitination and proteasomal degradation.
Purpose of the Study:
- To propose a novel therapeutic strategy targeting the Keap1-Nrf2 pathway.
- To explore small molecule modulation of Keap1 protein:protein interactions.
- To enhance Nrf2 nuclear accumulation and subsequent ARE-dependent gene transcription.
Main Methods:
- Elucidation of the structural interactions within the Keap1-ubiquitin ligase complex.
- Hypothesizing small molecule-mediated disruption of Keap1 interactions.
- Focus on promoting Nrf2 nuclear translocation.
Main Results:
- Detailed structural studies of the Keap1 complex have been recently published.
- This work proposes a mechanism for modulating Keap1 interactions.
- The proposed mechanism aims to increase Nrf2 levels and activity.
Conclusions:
- Modulating Keap1 protein:protein interactions is a potential therapeutic avenue.
- This strategy could lead to increased nuclear accumulation of Nrf2.
- Enhanced transcription of ARE-dependent genes may improve cellular resistance to oxidative stress.
Related Concept Videos
Anaphase Promoting Complex
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...